Parkinson-linked genes and toxins that affect neuronal cell death through the Bcl-2 family

Douglas W Ethell1, Qingyan Fei

  • 1Division of Biomedical Sciences, University of California Riverside, Riverside, California 92521-0121, USA. dougeth64@gmail.com

Insights

Parkinson's disease involves neuronal death due to oxidative stress from toxins and gene mutations impacting alpha-synuclein processing. This leads to programmed cell death, affecting mitochondria and protein degradation pathways.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • Parkinson's disease (PD) is characterized by the loss of specific neurons in the central nervous system.
  • Environmental toxins and genetic mutations are implicated in PD pathogenesis, particularly concerning alpha-synuclein processing.
  • Oxidative stress plays a crucial role, inducing cellular damage and programmed cell death.

Purpose of the Study:

  • To elucidate the cell death mechanisms involved in Parkinson's disease pathophysiology.
  • To connect the roles of environmental toxins, genetic mutations, and alpha-synuclein aggregation in PD.
  • To highlight the interplay between mitochondrial dysfunction and ubiquitin-proteasome system activity in dopaminergic neuron loss.

Main Methods:

  • Review of existing literature on neurotoxins (MPTP, paraquat, maneb, rotenone) and their effects.
  • Analysis of familial Parkinson's disease-linked mutations (Parkin, Uch-L1, DJ-1, PINK1).
  • Examination of the role of Bcl-2 family proteins, Bax, Bak, and mitochondrial outer-membrane permeabilization in cell death.

Main Results:

  • Neurotoxins and PD-linked mutations induce oxidative stress, leading to lipid peroxidation and protein misfolding.
  • Alpha-synuclein aggregate formation is a hallmark of PD, triggered by toxins and mutations.
  • Dysregulation of mitochondrial function and the ubiquitin-proteasome system are key contributors to dopaminergic neuron death.

Conclusions:

  • Oxidative stress is a central mechanism in Parkinson's disease, affecting both mitochondrial integrity and protein degradation.
  • The identified genetic factors and environmental toxins converge on common cell death pathways.
  • Understanding these interconnected mechanisms is vital for developing therapeutic strategies for Parkinson's disease.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...